Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (ZNF671) Predicts Poor Prognosis in Multiple Solid Tumors
- 1Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
- 2State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
- 3State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
- 4Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
A Corrigendum on
Epigenetic-mediated downregulation of zinc finger protein 671 (ZNF671) predicts poor prognosis in multiple solid tumors
by Zhang J, Zheng Z, Zheng J, Xie T, Tian Y, Li R, Wang B, Lin J, Xu A, Huang X and Yuan Y (2019) Front. Oncol. 9:342. doi: 10.3389/fonc.2019.00342
In the published article, there was an error in Figure 6 as published. Due to incorrect use of images, we found a minor error in the HOS-ZNF671 (D). We repeated the experiments and corrected the results. The corrected Figure 6 and its caption appear below.
Figure 6 Effects of ZNF671 overexpression on cell proliferation, migration, and invasion in vitro. (A) Representative Western blot analysis of ZNF671 overexpression in MCF7, Hela, PC9, PANC1, and HOS cell lines. (B) The CCK-8 assay showed overexpression of ZNF671 reduced the viability of MCF7, Hela, PC9, PANC1, and HOS cells. (C, D) Representative images of the effects of ZNF671 overexpression on migratory and invasive abilities of cells as determined by Transwell migration (C) and invasion (D) assays. (E) Quantification of the effects of ZNF671 overexpression on migratory and invasive abilities. All of the experiments were performed at least three times. Data presented are the mean ± SD; **P < 0.01 compared with control using Student’s t-test.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: epigenetic, ZNF671, prognosis, solid tumor, data mining
Citation: Zhang J, Zheng Z, Zheng J, Xie T, Tian Y, Li R, Wang B, Lin J, Xu A, Huang X and Yuan Y (2023) Corrigendum: Epigenetic-mediated downregulation of zinc finger protein 671 (ZNF671) predicts poor prognosis in multiple solid tumors. Front. Oncol. 13:1334056. doi: 10.3389/fonc.2023.1334056
Received: 06 November 2023; Accepted: 09 November 2023;
Published: 20 November 2023.
Edited and Reviewed by:
Matiullah Khan, AIMST University, MalaysiaCopyright © 2023 Zhang, Zheng, Zheng, Xie, Tian, Li, Wang, Lin, Xu, Huang and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yawei Yuan, eXVhbnlhd2VpQGd6aG11LmVkdS5jbg==
†These authors have contributed equally to this work